nuvox_logo 1000 - svg.jpg
  • Pipeline

  • Leadership

  • News

  • Publications

  • Careers

  • Contact

  • More

    Oncology

    A Phase Ib/II clinical trial of DDFPe as a radiosenzitizer in glioblastoma

    Although small, this trial shows that DDFPe used as a radiosensitizer appears to be safe and may provide some survival benefit.

    TOLD MRI validation of reversal of tumor hypoxia in glioblastoma with a novel oxygen therapeutic

    MRI scans indicated that oxygen breathing with DDFPe administration improved tumor oxygenation.

    Reversal of Tumor hypoxia following intravenous delivery of DDFPe

    DDFPe results in a significant increase in intra-tumoral oxygen tension for up to 45 minutes in our pancreatic xenograft model in mice.

    Dynamic Oxygenation Measurements Using a Phosphorescent Coating Window Chamber Model

    Intravenous injection of DDFPe in mice with tumors increases tumor oxygen levels.

    Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with DDFPe

    DDFPe administration in mice with pancreatic tumor xenografts resulted in increased tumor oxygen tension lasting up to two hours.

    Radiosensitization of hypoxic tumor cells by DDFPe

    DDFP plus carbogen appears to completely reverse the hypoxic cell radioresistance in this rat tumor model.
    • Pipeline
      • Leadership
        • News
          • Events
          • Publications
            • Acute Hypoxemic Respiratory Failure
              • Hemorrhagic Shock
                • Mechanism Of Action
                  • Myocardial Infarction
                    • Oncology
                      • Pharmacokinetics
                        • Stroke
                          • Traumatic Brain Injury
                          • Careers
                            • Contact

                              NuvOx Pharma

                              1635 E 18th Street

                              Tucson, Arizona 85719

                              ​

                              Privacy Policy

                              Terms & Conditions

                              ​

                              © 2020 NuvOx Pharma